Mukthiyar Ahamed*

REAL-WORLD SAFETY PROFILE OF TIRZEPATIDE: A DESCRIPTIVE ANALYSIS OF THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS)

Background: Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for the management of type 2 diabetes mellitus and obesity. Although clinical trials have demonstrated its efficacy and accepta...